-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Upgrades West Pharmaceutical Servs to Overweight, Raises Price Target to $400

Benzinga·09/22/2026 10:38:04
Diffusion vocale
Morgan Stanley analyst Kallum Titchmarsh upgrades West Pharmaceutical Servs (NYSE:WST) from Equal-Weight to Overweight and raises the price target from $365 to $400.